The rationale of prevention of thrombosis by enhancing blood levels of single-chain urokinase-type plasminogen activator (scuPA)
Dooijewaard, G; van Boheemen, P A; Binnema, D J; Kluft, C
An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein
Binnema, Doede J.; Dooijewaard, G.; Turion, P.N.
The contact-system dependent plasminogen activator from human plasma
Binnema, D J; Dooijewaard, G; van Iersel, J J; Turion, P N; Kluft, C
Production of plasminogen activators and inhibitor by serially propagated endothelial cells from adult human blood vessels
van Hinsbergh, V W; Binnema, D; Scheffer, M A; Sprengers, E D; Kooistra, T; Rijken, D C
Identification of two types of protein immunochemically related to urinary urokinase occurring in human plasma
Binnema, D J; Dooijewaard, G; van Iersel, J J
Quantitation of urokinase antigen in plasma and culture media by use of an ELISA
Binnema, D J; van Iersel, J J; Dooijewaard, G
Specific fibrinolytic properties of different molecular forms of pro-urokinase from a monkey kidney cell culture
Rijken, D.C.; Binnema, D.J.; Los, P.